Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease.

Sankaran-Walters S, Ransibrahmanakul K, Grishina I, Hung J, Martinez E, Prindiville T, Dandekar S.

J Clin Virol. 2011 Jan;50(1):31-6. doi: 10.1016/j.jcv.2010.09.011. Epub 2010 Oct 28.

2.

Differential cellular localization of Epstein-Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease.

Ciccocioppo R, Racca F, Scudeller L, Piralla A, Formagnana P, Pozzi L, Betti E, Vanoli A, Riboni R, Kruzliak P, Baldanti F, Corazza GR.

Immunol Res. 2016 Feb;64(1):191-203. doi: 10.1007/s12026-015-8737-y.

PMID:
26659090
3.

Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.

Ciccocioppo R, Racca F, Paolucci S, Campanini G, Pozzi L, Betti E, Riboni R, Vanoli A, Baldanti F, Corazza GR.

World J Gastroenterol. 2015 Feb 14;21(6):1915-26. doi: 10.3748/wjg.v21.i6.1915.

5.

Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.

Nissen LH, Nagtegaal ID, de Jong DJ, Kievit W, Derikx LA, Groenen PJ, van Krieken JH, Hoentjen F.

J Crohns Colitis. 2015 May;9(5):398-403. doi: 10.1093/ecco-jcc/jjv040. Epub 2015 Mar 4.

PMID:
25740811
6.
7.

Anti-TNFα therapy for inflammatory bowel diseases is associated with Epstein-Barr virus lytic activation.

Lapsia S, Koganti S, Spadaro S, Rajapakse R, Chawla A, Bhaduri-McIntosh S.

J Med Virol. 2016 Feb;88(2):312-8. doi: 10.1002/jmv.24331. Epub 2015 Aug 31.

PMID:
26307954
8.

Epstein-Barr virus infection is common in inflamed gastrointestinal mucosa.

Ryan JL, Shen YJ, Morgan DR, Thorne LB, Kenney SC, Dominguez RL, Gulley ML.

Dig Dis Sci. 2012 Jul;57(7):1887-98. doi: 10.1007/s10620-012-2116-5. Epub 2012 Mar 13.

9.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410
10.

Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.

Morishima S, Nakamura S, Yamamoto K, Miyauchi H, Kagami Y, Kinoshita T, Onoda H, Yatabe Y, Ito M, Miyamura K, Nagai H, Moritani S, Sugiura I, Tsushita K, Mihara H, Ohbayashi K, Iba S, Emi N, Okamoto M, Iwata S, Kimura H, Kuzushima K, Morishima Y.

Leuk Lymphoma. 2015 Apr;56(4):1072-8. doi: 10.3109/10428194.2014.938326. Epub 2014 Aug 13.

PMID:
24975317
11.

Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.

Magro F, Santos-Antunes J, Albuquerque A, Vilas-Boas F, Macedo GN, Nazareth N, Lopes S, Sobrinho-Simões J, Teixeira S, Dias CC, Cabral J, Sarmento A, Macedo G.

Inflamm Bowel Dis. 2013 Jul;19(8):1710-6. doi: 10.1097/MIB.0b013e318281f31c.

PMID:
23574759
12.

Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.

Petrara MR, Cattelan AM, Zanchetta M, Sasset L, Freguja R, Gianesin K, Cecchetto MG, Carmona F, De Rossi A.

J Clin Virol. 2012 Mar;53(3):195-200. doi: 10.1016/j.jcv.2011.12.013. Epub 2011 Dec 30.

PMID:
22209290
13.

Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas.

Wong NA, Herbst H, Herrmann K, Kirchner T, Krajewski AS, Moorghen M, Niedobitek F, Rooney N, Shepherd NA, Niedobitek G.

J Pathol. 2003 Oct;201(2):312-8.

PMID:
14517849
14.

Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.

Stevens SJ, Smits PH, Verkuijlen SA, Rockx DA, van Gorp EC, Mulder JW, Middeldorp JM.

AIDS. 2007 Oct 18;21(16):2141-9.

PMID:
18090040
15.

Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.

Leong IT, Fernandes BJ, Mock D.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Aug;92(2):184-93.

PMID:
11505266
16.

Epstein-Barr virus infection of the colon with inflammatory bowel disease.

Yanai H, Shimizu N, Nagasaki S, Mitani N, Okita K.

Am J Gastroenterol. 1999 Jun;94(6):1582-6.

PMID:
10364028
18.

Immune activation suppresses initiation of lytic Epstein-Barr virus infection.

Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M, Niggli FK, Speck RF, Nadal D.

Cell Microbiol. 2007 Aug;9(8):2055-69. Epub 2007 Apr 5.

PMID:
17419714
19.

Epstein-barr virus-related diarrhea or exacerbation of inflammatory bowel disease: diagnostic dilemma.

Weinberg I, Neuman T, Margalit M, Ayman F, Wolf DG, Ben-Yehuda A.

J Clin Microbiol. 2009 May;47(5):1588-90. doi: 10.1128/JCM.02477-08. Epub 2009 Mar 11.

20.

Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers.

Maurmann S, Fricke L, Wagner HJ, Schlenke P, Hennig H, Steinhoff J, Jabs WJ.

J Clin Microbiol. 2003 Dec;41(12):5419-28.

Supplemental Content

Support Center